Related Experiment Video
Updated: Aug 2, 2026

Cell-based Calcium Assay for Medium to High Throughput Screening of TRP Channel Functions using FlexStation 3
Published on: August 17, 2011
Farnesol blocks the L-type Ca2+ channel by targeting the alpha 1C subunit
U C Luft1, R Bychkov, M Gollasch
1Franz Volhard Clinic and Max Delbrück Center for Molecular Medicine, Virchow Klinikum-Charité, Humboldt University of Berlin, Berlin, Germany. luft@fvk-berlin.de
Farnesol, an isoprenoid, inhibits L-type calcium channels in vascular smooth muscle cells. This compound lowers blood pressure in hypertensive rats, suggesting it acts as an endogenous calcium channel antagonist.
Area of Science:
- Pharmacology
- Cardiovascular Physiology
- Molecular Biology
Background:
- Farnesol, a 15-carbon isoprenoid, has been shown to block L-type Ca2+ channels in vascular smooth muscle cells.
- Understanding the mechanism of farnesol's action on these channels is crucial for its potential therapeutic applications.
Purpose of the Study:
- To elucidate the mechanism of action of farnesol on L-type Ca2+ channels.
- To investigate whether farnesol acts as a G protein-dependent or independent inhibitor.
- To determine the effect of farnesol on blood pressure in vivo.
Main Methods:
- Whole-cell and perforated-patch clamp electrophysiology in rat aortic A7r5 and CHO C9 cells expressing Ca2+ channel alpha 1C subunits.
- G-protein inhibition assays using guanosine-5'-O-(2-thiodiphosphate).
- In vivo administration of farnesol to hypertensive and normotensive rats.
Main Results:
- Farnesol inhibited Ba2+ currents in a dose-dependent and voltage-independent manner in both cell lines.
- The inhibition was G protein-independent and shifted the steady-state inactivation curve negatively.
- Farnesol significantly reduced blood pressure in hypertensive rats for at least 48 hours.
Conclusions:
- Farnesol acts as a G protein-independent antagonist of smooth muscle L-type Ca2+ channels.
- The pore-forming alpha1 subunit is likely the molecular target for farnesol.
- Farnesol exhibits a blood pressure-lowering effect in vivo, suggesting therapeutic potential.
Related Concept Videos
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Local Anesthetics: Mechanism of Action
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
Antihypertensive Drugs: Action of Calcium Channel Blockers

